Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    August 2017
  1. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Text format     Abstract available


    July 2017
  2. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.
    PubMed     Text format    


  3. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    A Point-based Prediction Model for Cardiovascular Risk in Orthotopic Liver Transplantation: The CAR-OLT Score.
    Hepatology. 2017 Jul 13. doi: 10.1002/hep.29329.
    PubMed     Text format     Abstract available


    June 2017
  4. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Text format     Abstract available


  5. KWONG AJ, Goel A, Mannalithara A, Kim WR, et al
    Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29301.
    PubMed     Text format     Abstract available


    May 2017
  6. GANE E
    Is HBIG still needed after liver transplantation for CHB?
    Hepatology. 2017 May 26. doi: 10.1002/hep.29292.
    PubMed     Text format    


  7. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Text format     Abstract available


  8. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Text format     Abstract available


  9. SAXENA V, Khungar V, Verna EC, Levitsky J, et al
    Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29258.
    PubMed     Text format     Abstract available


    March 2017
  10. FUNG J, Wong T, Chok K, Chan A, et al
    Long Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B after Liver Transplantation: Results up to 8 years.
    Hepatology. 2017 Mar 31. doi: 10.1002/hep.29191.
    PubMed     Text format     Abstract available


  11. AHMED A, Gonzalez SA, Cholankeril G, Perumpail RB, et al
    Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29137.
    PubMed     Text format     Abstract available


  12. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Text format     Abstract available


    February 2017
  13. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available


  14. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


    January 2017
  15. VERNA EC
    The Dynamic Landscape of Liver Transplant in the Era of Effective HCV Therapy.
    Hepatology. 2017 Jan 17. doi: 10.1002/hep.29054.
    PubMed     Text format    


  16. SHAKED A, Chang BL, Barnes MR, Sayre P, et al
    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:269-280.
    PubMed     Text format     Abstract available


    December 2016
  17. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  18. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  19. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  20. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


    November 2016
  21. DE VRIES EM, de Krijger M, Farkkila M, Arola J, et al
    Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis; An International Cohort Study.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28963.
    PubMed     Text format     Abstract available


  22. CHHATWAL J, Samur S, Kues B, Ayer T, et al
    Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28926.
    PubMed     Text format     Abstract available


  23. FLEMMING JA, Kim WR, Brosgart CL, Terrault NA, et al
    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28923.
    PubMed     Text format     Abstract available


    October 2016
  24. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Text format     Abstract available


  25. EMOND JC, Griesemer AD
    Tolerance in clinical liver transplantation: The long road ahead.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28862.
    PubMed     Text format    


    August 2016
  26. TAWAR RG, Heydmann L, Bach C, Schuttrumpf J, et al
    Broad neutralization of hepatitis C virus resistant variants by Civacir(R) hepatitis C immune globulin.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28767.
    PubMed     Text format     Abstract available


  27. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


    June 2016
  28. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available


    May 2016
  29. YANG CH, Gombar S, Twist CJ, Gratzinger D, et al
    Plasmacytic post-transplant lymphoproliferative disorder with hyperviscosity syndrome in a child after liver transplant.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28657.
    PubMed     Text format    


  30. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


    March 2016
  31. GUTIERREZ JA, Landaverde C, Wells JT, Poordad F, et al
    Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28556.
    PubMed     Text format    


  32. FRIEDRICH K, Smit M, Brune M, Giese T, et al
    CD14 is associated with biliary stricture formation.
    Hepatology. 2016 Mar 11. doi: 10.1002/hep.28543.
    PubMed     Text format     Abstract available


  33. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    January 2016
  34. TODO S, Yamashita K, Goto R, Zaitsu M, et al
    A Pilot Study of Operational Tolerance with a Regulatory T Cell-Based Cell Therapy in Living Donor Liver Transplantation.
    Hepatology. 2016 Jan 16. doi: 10.1002/hep.28459.
    PubMed     Text format     Abstract available


  35. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  36. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  37. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


    December 2015
  38. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


    November 2015
  39. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  40. YAO FY, Fidelman N
    Re-accessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand with Tumor Down-staging?
    Hepatology. 2015 Nov 11. doi: 10.1002/hep.28139.
    PubMed     Text format     Abstract available


  41. CAVALLIN M, Piano S, Angeli P
    Outpatients use of terlipressin for hepatorenal syndrome: Not for all, with caution and a wise liver transplant allocation policy.
    Hepatology. 2015 Nov 2. doi: 10.1002/hep.28324.
    PubMed     Text format    


    October 2015
  42. LAI JC, Dodge JL, Sen S, Covinsky K, et al
    Functional Decline in Patients with Cirrhosis Awaiting Liver Transplantation: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28316.
    PubMed     Text format     Abstract available


  43. AGUERO F, Forner A, Manzardo C, Valdivieso A, et al
    HIV Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28321.
    PubMed     Text format     Abstract available


  44. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  45. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  46. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


    September 2015
  47. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


    August 2015
  48. ANTOINE DJ, Sabbisetti VS, Francis B, Jorgensen AL, et al
    Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury.
    Hepatology. 2015;62:591-9.
    PubMed     Text format     Abstract available


    July 2015
  49. BHARADWAJ S, Rivas JM, Jevenn A, Hanouneh I, et al
    Immunonutrition in Patients undergoing Liver Transplantation- Too Premature to Draw Conclusions.
    Hepatology. 2015 Jul 23. doi: 10.1002/hep.28004.
    PubMed     Text format    


  50. BAJAJ JS
    Liver Capsule: Hepatic Encephalopathy.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27984.
    PubMed     Text format    


  51. KIRSTEIN MM, Metzler F, Geiger E, Heinrich E, et al
    Prediction of short- and long-term outcome in patients with autoimmune hepatitis.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27983.
    PubMed     Text format     Abstract available


  52. GUSTOT T, Fernandez J, Garcia E, Morando F, et al
    Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.
    Hepatology. 2015;62:243-52.
    PubMed     Text format     Abstract available


    May 2015
  53. ZAMBAM DE MATTOS A, Alves de Mattos A
    Hepatocellular carcinoma - to resect or to transplant?
    Hepatology. 2015 May 29. doi: 10.1002/hep.27919.
    PubMed     Text format    


  54. MORITA M, Joyce D, Miller C, Fung JJ, et al
    Rejection triggers liver transplant tolerance: Involvements of mesenchyme-mediated Immune Control Mechanisms.
    Hepatology. 2015 May 22. doi: 10.1002/hep.27909.
    PubMed     Text format     Abstract available


    April 2015
  55. BANERJEE S, Wang DS, Kim HJ, Sirlin CB, et al
    A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
    Hepatology. 2015 Apr 30. doi: 10.1002/hep.27877.
    PubMed     Text format     Abstract available


    March 2015
  56. TOSO C, Meeberg G, Hernandez-Alejandro R, Dufour JF, et al
    Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
    Hepatology. 2015 Mar 17. doi: 10.1002/hep.27787.
    PubMed     Text format     Abstract available


    October 2014
  57. NAVARRO VJ, Barnhart H, Bonkovsky HL, Davern T, et al
    Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
    Hepatology. 2014;60:1399-408.
    PubMed     Text format     Abstract available


    September 2014
  58. HALAZUN KJ, Rana AA, Patzer RE, Samstein B, et al
    Re: - Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem.
    Hepatology. 2014 Sep 11. doi: 10.1002/hep.27435.
    PubMed     Text format    


  59. LAI Q, Lerut J
    Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem.
    Hepatology. 2014 Sep 11. doi: 10.1002/hep.27434.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: